Enteral Lipid Supplement Reduces Severe Retinopathy Risk in Preterm Infants

Extremely premature infants who receive enteral lipid supplementation starting within 3 days of birth have a lower risk of severe retinopathy of prematurity than without supplementation, a clinical trial suggests, according to a Reuters report.

Researchers randomly selected 206 infants born at less than 27 weeks’ gestation to receive no supplementation or to initiate supplementation with an enteral oil containing arachidonic acid (AA, 100 mg/kg/day) and docosahexaenoic acid (DHA, 50 mg/kg/day). Those in the supplement group continued this intervention until they reached 40 weeks postmenstrual age.

Read the full article.